InvestorRoom | Kitov Pharmaceuticals http://kitovpharma.investorroom.com/ Kitov to Present Data on NT219 in Combination with Keytruda® and Erbitux® at AACR International Cancer Immunotherapy Conference http://kitovpharma.investorroom.com/news-releases?item=69 Treatment with NT219 in combination with Keytruda® or Erbitux® converted non-responding tumors to responders Wed, 26 Sep 2018 05:38:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=69 Kitov Pharma Updates on Motions in USA Initiated by Kitov Chairman http://kitovpharma.investorroom.com/news-releases?item=70 Tue, 18 Sep 2018 05:42:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=70 Kitov Pharma Provides Corporate Update and Reports First Half 2018 Financial Results http://kitovpharma.investorroom.com/news-releases?item=68 Wed, 29 Aug 2018 03:04:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=68 Kitov Announces Settlement of Shareholder Class Action Litigation http://kitovpharma.investorroom.com/news-releases?item=67 Mon, 30 Jul 2018 19:47:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=67 Kitov to Host Business Update Conference Call on Monday, July 2 http://kitovpharma.investorroom.com/news-releases?item=66 Wed, 27 Jun 2018 03:23:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=66